King Bio-Medical代理03
简要描述:King Bio-Medical代理,King Bio-Medical上海代理,King Bio-Medical北京代理,King Bio-Medical 代理,King Bio-Medical一级代理,King Bio-Medical国内代理上海金畔生物科技有限公司King Bio-Medical专业代理,具体产品信息欢迎电询:021-50837765
详细介绍
产品咨询
King Bio-Medical代理,King Bio-Medical上海代理,King Bio-Medical北京代理,King Bio-Medical 代理,King Bio-Medical一级代理,King Bio-Medical国内代理
上海金畔生物科技有限公司King Bio-Medical专业代理,具体产品信息欢迎电询:
Congenital Factor II Deficient Plasma
Factor II Deficient plasma is drawn from a human donor with a congenital deficiency.
· Human plasma from donor with congenital FII Deficiency
· Substrate quality
· FII Activity printed on each vial
· No buffers or preservatives added
When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).
Congenital Factor V Deficient Plasma
· Human plasma from donor with congenital FV Deficiency
· Substrate quality
· <1% FV Activity by one stage clotting assay
· No buffers or preservatives added
When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).
Congenital Factor VII Deficient Plasma
Factor VII Deficient plasma is drawn from a human donor with a congenital deficiency.
· Human plasma from donor with congenital FVII Deficiency
· Substrate quality
· <1% FVII Activity by one stage clotting assay
· No buffers or preservatives added
When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).
Congenital Factor VIII Deficient Plasma
Factor VIII Deficient plasma is drawn from a human donor with a congenital deficiency.
· Human plasma from donor with congenital FVIII Deficiency
· Substrate quality
· <1% FVIII Activity by one stage clotting assay
· No buffers or preservatives added
When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).
Congenital Factor IX Deficient Plasma
Factor IX Deficient plasma is drawn from a human donor with a congenital deficiency.
· Human plasma from donor with congenital FIX Deficiency
· Substrate quality
· <1% IX Activity by one stage clotting assay
· No buffers or preservatives added
When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).
上海金畔生物科技有限公司